Law Offices of Gary Martin Hays & Associates
P.C.
75 Ponce De Leon Ave NE Ste 101
Atlanta,
GA 30308(470) 294-1674
www.garymartinhays.com
By njlawjournal | New Jersey Law Journal | August 23, 2017
Claims of Favorable Reverse Payment Settlement Agreements Were Sufficient to Constitute Allegation of Anticompetitive Activity
By Charles Toutant | August 21, 2017
The U.S. Court of Appeals for the Third Circuit has overturned the dismissal of two antitrust suits over "reverse settlements" in which patent holders sought to delay the sale of generic versions of blockbuster drugs.
By Amanda Bronstad | August 18, 2017
In lobbying and litigation, the U.S. Chamber of Commerce and Johnson & Johnson often draw from the same playbook. One major connection is John Beisner, head of mass torts at Skadden Arps.
By Max Mitchell | August 17, 2017
Mylan has agreed to pay $465 million to settle claims that the Pennsylvania-based drugmaker misclassified its EpiPen allergy medication to avoid paying Medicaid rebates.
By Max Mitchell | August 15, 2017
The dispute between generic drugmakers Apotex and Teva stemming from a former Teva executive's alleged disclosure of trade secrets to an Apotex CEO while the two were dating is heating up, with the parties now sparring over the speed of discovery.
By Michael Booth | August 14, 2017
Kenneth Frazier, the chairman and CEO of pharmaceutical giant Merck & Co. and a member of President Donald Trump's American Manufacturing Council, abruptly quit the administration's advisory committee following Trump's response to right-wing violence in Charlottesville, Virginia.
By Amanda Bronstad | August 8, 2017
A federal judicial panel has transferred more than 200 cases to New Jersey involving heartburn medications Nexium and Prilosec just six months after it refused a similar request.
By njlawjournal | New Jersey Law Journal | August 3, 2017
Trial Court Erred in Precluding Expert Testimony Using Reasonable Scientific Evidence Other Than Epidemiological Studies to Reject Such Studied Cited by Defendants
By Charles Toutant | July 28, 2017
More than 2,100 suits by users of the acne drug Accutane who developed Crohn's disease have been reinstated after an appeals court ruled that expert testimony on behalf of plaintiffs was improperly excluded by the trial judge.
By Charles Toutant | July 26, 2017
A state appeals court has revived more than 300 suits filed against Hoffmann-La Roche by users of the acne drug Accutane who claim the drug caused them to develop inflammatory bowel disease.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...